Gavrilov Ognian Anguelov 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-31 4:58 pm Sale | 2026-03-31 | 13D | CALIDI BIOTHERAPEUTICS INC CL CLDI | Gavrilov Ognian Anguelov | 1,250 0.300% | -42,500 (-97.14%) | Filing |
| 2026-03-09 1:15 pm Purchase | 2026-03-09 | 13D | CALIDI BIOTHERAPEUTICS INC CL CLDI | Gavrilov Ognian Anguelov | 43,750 9.800% | 8,750 (+25.00%) | Filing |
| 2026-02-04 3:06 pm Purchase | 2025-08-20 | 13G | CALIDI BIOTHERAPEUTICS INC CL CLDI | Gavrilov Ognian Anguelov | 35,000 7.800% | 35,000 (New Position) | Filing |